Gordon Empey - Profile and Investment Details

Investor Profile

Gordon Empey is a Venture Capital, Private Equity Firm, Investor based in Bellevue, Washington, United States with a diverse investment portfolio that includes companies such as Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics, Zavante Therapeutics, Calistoga Pharmaceuticals, Chimerix, Alnara Pharmaceuticals, Nuon Therapeutics, Stemgent, Moximed, Incline Therapeutics, VentiRx Pharmaceuticals, Calibra Medical, Mirum Pharmaceuticals, Intradigm Corporation, Tarsus Pharmaceuticals, Alpine Immune Sciences, Aptinyx, Alcresta, Barosense, Silvergate Pharmaceuticals, Dascena, Cirius Therapeutics, Outpost MedicineRempex Pharmaceuticals, Aspen Neuroscience, Collegium Pharmaceutical, Seraxis, Calibrium, Mavupharma, Inipharm, Sierra Oncology, PatientKeeper, Kalidex Pharmaceuticals, AcertaPharma, Merganser Biotech, AnaptysBio, Sojournix, Iovance Biotherapeutics, Portola Pharmaceuticals, EBR Systems, Imago BioSciences, MBX Biosciences, Vaxcyte, Primaeva Medical, Millendo Therapeutics, Clovis Oncology, Achaogen, Scout Bio, Cadence Pharmaceuticals, Passage Bio, Recida Therapeutics, Amunix, Phathom Pharmaceuticals, Lengo Therapeutics, Tobira Therapeutics, PowerVision, Calypso Medical, Cidara Therapeutics, Semnur Pharmaceuticals, CVRx, Gritstone Oncology, Glaukos, PreCision Dermatology, Threshold Pharmaceuticals, Iterum Therapeutics, Alteon Health, Arcutis Biotherapeutics, Entasis Therapeutics, Allena Pharmaceuticals, Laguna Pharmaceuticals, . Over time, Gordon Empey has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Gordon Empey is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Life Science, Engineering, Portfolio Management, Finance, Biotechnology, Drug Development, Clean Technology, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Digital Health, Developer Tools, Medical, Information Technology, B2B, Therapeutics, Machine Learning, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Gordon Empey, as their portfolio suggests a familiarity and interest in this area.

Understanding Gordon Empey’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.